Capricor Therapeutics Inc (CAPR)

[megabandp]

HUGE: Peer Reviewed Publication: CAP-1002 in Critically Ill Patients – Compassionate Use Case Series (May 2020) Publication Here

http://www.globenewswire.com/news-release/2020/05/14/2033829/0/en/Capricor-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html



Duchenne Muscular Dystrophy Program
-Final Top-Line 12-month Results from Phase II Randomized, Double-blind, Placebo-controlled HOPE-2- Study Demonstrated Improved Performance of Upper Limb (PUL) 2.0 (p=0.05)-

COVID-19 Program
-COVID-19 Compassionate Use Case Series Published in Peer Reviewed Journal-

-Reported 100 Percent Survival in Critical COVID-19 Patients Treated with CAP-1002 Under Compassionate Use Pathway-

-Expanded Access Protocol Approved by FDA to Treat Critical COVID-19 Patients-

-Appointed Stephen J. Gould, Ph.D. to lead Capricor’s Exosome-Based Platform Vaccine Approach Against COVID-19-

-To Host Conference Call and Webcast Today at 4:30 p.m. ET-